| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |